SHERWIN STEPHEN A

SEC Form 4 insider trading activity

SHERWIN STEPHEN A has filed 5 SEC Form 4 filings (11 transaction rows) across 2 companies, including NBIX, BIIB, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.

On the most recent filing, SHERWIN STEPHEN A is listed as Director at NEUROCRINE BIOSCIENCES INC. Inside the rolling window, SHERWIN STEPHEN A reported no open-market purchases and 1 open-market sale totaling $4.1M in NBIX.

Companies traded

Other insiders at NBIX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$4.1M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
NBIX
SHERWIN STEPHEN A
Sale$4.1MJun 9SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has SHERWIN STEPHEN A made?

SHERWIN STEPHEN A has filed 5 SEC Form 4 filings (11 transaction rows) across 2 companies, including NBIX, BIIB since 2025.

Which companies does SHERWIN STEPHEN A trade?

SHERWIN STEPHEN A has filed SEC Form 4 disclosures for 2 companies, including NBIX, BIIB.

When was SHERWIN STEPHEN A's most recent SEC Form 4 filing?

SHERWIN STEPHEN A's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.

What is SHERWIN STEPHEN A's total buy and sell value in the current window?

Inside the rolling retention window, SHERWIN STEPHEN A bought $0 and sold $4.1M based on SEC Form 4 filings.

What was SHERWIN STEPHEN A's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 25,000 NBIX shares on 2026-06-05, worth $4.1M, per SEC Form 4 filings.